[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100572246":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":35,"locations":45,"responsibleParty":60,"collaborators":25,"id":64,"slug":65,"hasResults":66,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":25,"eligibilityCriteria":70,"healthyVolunteers":66,"sex":71,"minAge":72,"maxAge":73,"enrollmentInfo":74,"targetDuration":25,"studyType":77,"phases":78,"briefSummary":80,"conditions":81,"keywords":83,"overallStatus":85,"whyStopped":25,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"Cairo University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Control group (group A)","ACTIVE_COMPARATOR","It will include 19 women with dyspareunia. They will receive only topical medication (lidocaine ointment applied as required for symptoms and 30 minutes before sexual activity)",[13],"Other: Topical medication",{"label":15,"type":16,"description":17,"interventionNames":18},"Study group (group B)","EXPERIMENTAL","It will include 19 women with dyspareunia. They will receive Acu-TENS (30 minutes per session, once per week for 10 weeks), topical medication(lidocaine ointment applied as required for symptoms and 30 minutes before sexual activity)",[13,19],"Other: Transcutaneous electrical acupoint stimulation",[21,26],{"type":6,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"Topical medication","It will be given to all participants in both groups (A\\&B). The most commonly prescribed topical medication is lidocaine ointment 5% (Xylocaine jelly 2% or ointment 5%; AstraZeneca Pharmaceuticals LP, Wilmington, DE), applied as required for symptoms and for 30 minutes before sexual activity.",[9,15],null,{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Transcutaneous electrical acupoint stimulation","This procedure will be applied for group B only. Before starting the first treatment session, each patient will be instructed briefly about the nature of the treatment to gain the patient's confidence and cooperation. This procedure will be performed by using TENS device on acupoints as the following: The participating woman will be placed in a relaxed comfortable supine position with her back well supported. The surface of the treated skin and the electrodes will be cleaned with alcohol wipe. The TENS protocol consists of a 30-minute weekly. session for 10 weeks of biphasic pulses with modulation 0\u002F10-50 Hz of frequency and 300\u002F100\u002F3000 microseconds of pulse duration (s). The intensity parameter will be adapted individually according to each woman's perception, and modulated so that it is applied without discomfort, ranging between 10 and 100 mA (pulsing sensation) (Dionisi and Senatori ,2011)",[15],[31],{"name":32,"affiliation":33,"role":34},"Doaa A Osman","Department of Women's Health, Faculty of Physical Therapy, Cairo University","STUDY_CHAIR",[36,41],{"name":37,"role":38,"phone":39,"phoneExt":25,"email":40},"Marwa GA Ahmed","CONTACT","01018637863","marwagamal30594@gmail.com",{"name":42,"role":38,"phone":43,"phoneExt":25,"email":44},"Manal A El-Shafei","01220664518","manal.ahmed@pt.cu.edu.eg",[46],{"facility":47,"status":25,"city":48,"state":49,"zip":50,"country":49,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":58},"Faculty of Physical Therapy","Giza","Egypt","12511","EG",{"type":53,"coordinates":54},"Point",[55,56],31.20861,30.00944,{"lat":56,"lon":55},[59],{"name":37,"role":38,"phone":39,"phoneExt":25,"email":40},{"type":61,"investigatorFullName":62,"investigatorTitle":63,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","Marwa gamal abdelrahman ahmed","Master student at Faculty of Physical Therapy, Cairo University","100572246","effect-of-transcutaneous-electrical-acupoint-stimulation-on-dyspareunia-100572246",false,"NCT06730776","Effect of Transcutaneous Electrical Acupoint Stimulation on Dyspareunia","Effect of Transcutaneous Electrical Acupoint Stimulation on Dyspareunia: a Randomized Controlled Trial","* Inclusion Criteria:\n\n  * Women complain of secondary dyspareunia, diagnosed and referred by the gynecologist.\n  * Multiparous women.\n  * Their ages will range from 25-35 years.\n  * Their body BMI will be less than 35 kg\u002Fm².\n  * Their pain level on the VAS will be ≥ 4.\n  * All the women were negative for vaginal infections caused by viruses, bacteria or fungi.\n* Exclusion Criteria:\n\n  * Pregnancy\n  * Malignancy.\n  * The presence of an intrauterine device, vaginal infection, or skin\u002Fmucous lesions.\n  * Diabetes mellitus.\n  * Dermatological abnormalities on the skin at acupuncture point.\n  * Severe uncontrolled cardiac patients or implanted cardiac rhythm devices.\n  * Dyspareunia with endometriosis.\n  * Fearing from electricity.","FEMALE","25 Years","35 Years",{"count":75,"type":76},38,"ESTIMATED","INTERVENTIONAL",[79],"NA","Transcutaneous electrical acupoint stimulation (TEAS)was proven to stimulate the secretion of endogenous opioid peptides which are partial substitutes for the exogenous opioids stimulated by drugs in the central nervous system and can thus relieve pain. Till now there is no previous study that investigates the effect of TEAS on dyspareunia. This study will determine the effect of transcutaneous acupoint stimulation on dyspareunia.\n\nPatients will be divided randomly into two groups equal in number: The control group will receive only topical medication. The study group will receive Acu-TENS and topical medication.",[82],"Dyspareunia (Female)",[84],"dyspareunia,","NOT_YET_RECRUITING","2024-12-09",{"date":88,"type":89},"2024-12-12","ACTUAL",{"date":91,"type":76},"2024-12-15",{"date":93,"type":76},"2025-05-30",{"name":5,"class":6},1]